Sanofi Pasteur, A Sanofi Company

This study tested a new vaccine designed to protect against H7N9 influenza, a type of bird flu. Researchers compared two different strengths of the vaccine mixed with an immune-boosting ingredient (MF59) to the vaccine alone in 581 healthy adults. The main goal was to see which f…

This study tested a new flu vaccine designed to protect against four strains of influenza, comparing it to standard vaccines that protect against three strains. It involved over 7,000 participants in China, from infants as young as 6 months to adults over 65. The main goals were …

This study tested the safety and immune response of a new pneumococcal vaccine (SP0202) in healthy infants and toddlers. The goal was to see how well it worked and how safe it was when given at the same time as other standard childhood vaccines. Researchers enrolled 852 children …

This study tested new protein-based COVID-19 vaccines made by Sanofi in over 3,000 adults. It checked how safe the vaccines were and how well they triggered an immune response against the virus, both for people getting their first shots and for people getting a booster dose. The …

This study tested whether a higher-dose flu shot creates a stronger immune response than the standard-dose shot in adults aged 50 to 64. About 1,180 participants received either the high-dose or standard vaccine. Researchers then measured antibody levels and tracked side effects …

This study tested a booster dose of a vaccine that protects against four types of meningococcal disease (A, C, W, Y). It involved 471 older adults who had received an initial meningitis vaccine at least three years earlier. The main goal was to see if the booster shot was safe an…

This study tested a new vaccine designed to protect against two common respiratory viruses, RSV and human metapneumovirus (hMPV), in adults aged 60 and older. Researchers gave 646 healthy participants a single shot to check for safety and to see if it triggered a strong immune re…

This study tested a yellow fever vaccine in healthy adults in Japan. Researchers gave a single shot to 254 participants and monitored them for one month to see if their bodies developed a strong immune response and to check for side effects. The goal was to gather safety and effe…

This study tested a new vaccine designed to protect against four major strains of meningococcal disease (A, C, W, Y) in healthy 10-17 year olds. Researchers compared the new vaccine's ability to trigger a protective immune response to an already approved vaccine. They also checke…

This first-in-human study tested the safety and immune response of a new vaccine designed to protect against two common respiratory viruses, RSV and hMPV, in adults aged 60 to 75. 385 participants received a single injection of either the combined vaccine or an RSV-only vaccine a…

This study tested a new combination vaccine (Shan6™) designed to protect infants against six serious diseases: diphtheria, tetanus, whooping cough, hepatitis B, Hib, and polio. It involved 460 healthy infants and toddlers in Thailand to see if the new vaccine worked as well as th…

This early-stage study tested three different doses of an experimental yellow fever vaccine in 73 healthy adults. Researchers compared the new vaccine's safety and ability to trigger protective immune responses against an already approved yellow fever vaccine. The main goal was t…

This study tested a new rabies vaccine designed to prevent infection before exposure. Over 1,700 healthy children and adults in Thailand received either the new vaccine or one of two existing vaccines to compare their safety and ability to trigger a protective immune response. Re…

This study tested a new type of flu vaccine made using recombinant technology against a standard egg-based flu shot. It involved 301 healthy adults in South Korea to see if the new vaccine triggered a similar or better immune response and was equally safe. The trial was a Phase 3…

This early-stage study tested the safety and immune response of a new mRNA-based flu vaccine in healthy adults. Researchers gave 233 participants different dose levels of the experimental vaccine and monitored them for side effects and antibody production for a year. The goal was…

This study tested several new versions of a flu vaccine to see how safe they were and if they could trigger a good immune response. It involved 210 healthy adults, split into groups receiving different formulas, some with an extra ingredient (adjuvant) to potentially boost effect…

This study tested a new nasal spray vaccine designed to protect infants and toddlers from Respiratory Syncytial Virus (RSV). Researchers gave the vaccine to 80 healthy children aged 6 to 24 months in Puerto Rico to see if the weakened virus in the vaccine could spread to other ch…

This study tested a new COVID-19 vaccine made from a lab-created protein, with and without an immune-boosting ingredient (adjuvant). It involved 441 healthy adults to see if the vaccine was safe and if it triggered a strong and lasting immune response against the virus. Researche…

This study looked at whether it's safe and effective to give a high-dose flu shot and a Moderna COVID-19 booster shot at the same time to adults aged 65 and older. Researchers compared giving both shots together versus giving them separately. They measured side effects and how we…

This study tested a new vaccine designed to protect infants and toddlers from four dangerous strains of meningococcal bacteria, which can cause meningitis and blood infections. It involved over 1,500 healthy babies in India and South Africa, comparing the new vaccine to an existi…

This study tested a new investigational vaccine designed to protect against four major strains of meningococcal disease (A, C, W, Y) in young children. It involved 707 healthy toddlers aged 12 to 23 months and directly compared the new vaccine's safety and ability to trigger a pr…

This study tested a new live but weakened RSV vaccine given as a nasal spray to see if it was safe and could trigger a protective immune response in young children. It involved 259 infants and toddlers aged 6 to 18 months. The main goals were to check for side effects and measure…

This study tested whether a high-dose flu vaccine works better than the standard-dose vaccine for people aged 60 and older. Over 1,500 healthy volunteers received either the stronger shot or the regular one. Researchers measured the body's immune response and tracked side effects…

This study monitored the safety of the Hexaxim vaccine, which protects against six diseases including hepatitis B and Hib, after it was given to infants as part of routine care in South Korea. Researchers tracked over 700 infants for about 5-6 weeks after vaccination to record an…

This study tested the safety and immune response of a new investigational vaccine designed to protect against five major groups (A, B, C, W, Y) of meningococcal bacteria, which can cause meningitis and bloodstream infections. It involved 1,215 healthy adolescents (10-17 years) an…

This study tested if a high-dose flu shot given as a muscle injection works better than a standard-dose shot given under the skin for people aged 60 and older in Japan. It involved 2,100 healthy volunteers and measured their immune response and safety 28 days after vaccination. T…

This study tested a booster dose of the MenQuadfi meningitis vaccine in healthy toddlers aged 12 to 23 months. The children had all received at least one dose of a different meningitis vaccine when they were babies. Researchers checked the children's blood before and after the bo…

This study tested a new version of the seasonal flu vaccine that includes an extra component (an H3 strain) to see if it is safe and how well it triggers an immune response. It involved about 400 healthy adults, split into younger (18-49) and older (60+) groups, who received diff…

This early-stage study tested the safety and immune response of a new mRNA vaccine designed to prevent serious lung infections caused by RSV and human metapneumovirus (hMPV). It involved 558 healthy adults, including people aged 60 and older, who received one of several different…

This study tested a new rabies vaccine to see if it works as well as two already approved vaccines. It involved 640 healthy adults in France who received a series of shots to simulate treatment after a potential rabies exposure. The main goal was to check if the new vaccine trigg…

This study tested a high-dose flu vaccine designed for adults aged 65 and older in Taiwan. Researchers compared it to a standard flu vaccine to see if it triggered a stronger immune response against four flu strains. They also monitored participants for 28 days to check for any s…

This study tested a new type of flu vaccine made using recombinant technology in people aged 9 to 49. The main goal was to see if the vaccine triggered a strong immune response in children and teens that was at least as good as the response in adults. Researchers also closely mon…

This study tested a new vaccine designed to protect infants and toddlers from four types of serious meningococcal disease (A, C, W, and Y). It compared the new vaccine to an existing one to see if they worked equally well and were similarly safe. The study involved 840 healthy ba…

This early-stage study tested the safety and immune response of a new mRNA flu vaccine in healthy adults. Researchers gave 159 participants one of several different doses of the experimental vaccine or a standard flu shot to compare. The main goal was to see if the new vaccine wa…

This study tested a booster dose of an investigational vaccine designed to protect against four types of meningococcal disease (A, C, Y, W). It involved 570 healthy adolescents and young adults who had received a similar vaccine 3 to 6 years earlier. The main goal was to see if t…

This study tested a single-dose vaccine designed to protect against four types of meningococcal disease (A, C, W, Y). It involved 447 healthy volunteers in Vietnam, aged 12 months and older, to see how well their immune systems responded and to check for side effects. Participant…

This study looked at how children's immune systems respond to a booster shot for whooping cough, tetanus, diphtheria, and polio. Researchers compared kids who received different types of whooping cough vaccines as babies to see if the early vaccine choice affects long-term protec…

This study tested how well a single antibody shot (nirsevimab) protects infants from serious Respiratory Syncytial Virus (RSV) infections during their first RSV season. It involved nearly 50,000 infants to see if the shot reduced doctor visits, emergency room trips, and hospitali…

This study tested a new rabies vaccine to see if it safely triggers a strong immune response when given after a potential rabies exposure. It involved 201 healthy adults in Thailand who received the vaccine along with protective antibodies, simulating a real-world bite scenario. …

This study tested a new rabies vaccine to see if it safely triggers a strong immune response to prevent rabies after a potential exposure. It involved 403 healthy children and adults in Thailand, comparing the new vaccine to an existing one. Researchers measured antibody levels a…

This study tested whether a single shot called nirsevimab could keep healthy infants under 1 year old out of the hospital due to RSV lung infections. Over 8,000 babies were randomly assigned to receive the shot or no intervention. Researchers then tracked them through the RSV sea…

This study aimed to find out how many people in Germany were getting their seasonal flu vaccine. Researchers surveyed 5,000 adults, with a focus on people aged 60 and older, to get up-to-date information. The goal was to provide data to help public health officials and doctors en…

This study collected blood samples from children (6 months to 9 years) and older adults (65+) after they received their annual flu vaccines. Researchers analyzed these samples to measure how well the body's immune system responded to the 2021-2022 vaccine formulas. The data helps…

This study collected blood samples from children and older adults after they received their annual flu shots. Researchers wanted to analyze how people's immune systems responded to the vaccines. The blood samples were sent to major health agencies to help them make better recomme…

This study collected blood samples from 90 healthy children (6 months to 9 years) and seniors (65+) who received standard flu vaccines. Researchers took blood before and after vaccination to analyze immune responses. The samples were sent to major health agencies to help them des…

This study aimed to better understand the biological connections between type 2 diabetes and gum disease (periodontitis). Researchers enrolled 226 adults, with and without these conditions, to collect blood and saliva samples. The goal was to measure immune system signals and bac…